Skip to: Content
Skip to: Site Navigation
Skip to: Search


One city's fight over biomed plans

The prospect of animal testing in a company laboratory provokes residents in Chandler, Ariz.

(Page 2 of 2)



Protesters of the plans decry the method that the US government requires for the development of medicines and other compounds such as antibacterial cleansers: that they be tested on animals before humans. Critics claim the method is outdated and that the toxins they introduce in animals cause them to react differently than humans. They also note that the US Department of Agriculture cited Covance for violations of the federal Animal Welfare Act in 2005.

Skip to next paragraph

But others point out that companies like Covance are following US regulations. "In this society, like all developed nations, any new compound, product, or medical device must be tested in a whole living system, and we do not test on humans first," says Frankie Trull, president of the Foundation for Biomedical Research, a group in Washington dedicated to fostering support for humane and responsible animal research. "The law and regulations are really quite proscriptive in what a company has to do."

Most test animals – some 95 percent – are rodents bred for that purpose, Ms. Trull says. But Covance also tests on some primates, as well as dogs.

Battle over the property

Those opposed to Covance are also furious with the city for its approval process. Covance first purchased property along what is known as the Price corridor, a section of land that follows the north-south freeway through the city. It was zoned for agricultural use, and in order for Covance to build its lab there, it would have had to be rezoned as light industrial. Opposition to Covance building on that property was strong.

Yet as opponents focused on the Price property, the lawsuit alleges that Covance conspired with the city to purchase another property at the Chandler Airpark. It further claims that this purchase happened through a "front" company, which allegedly obtained rezoning before selling it to Covance.

"All we're asking the court to do is set this process back to the beginning, undo what's been done, and have an honest and open process where everyone gets to ... be heard," says Dan Kinburn, the attorney representing PCRM.

Besides the rezoning issues, those opposed to Covance say they are concerned about the waste these animals eliminate – after ingesting large amounts of drugs – and the disposal of carcasses. "The city of Chandler has not been responsive to residents' concerns at all," says Jan McClellan, spokeswoman for Citizens Against Covance.

City officials, though, say they've researched Covance's potential impact. "We've looked very carefully at the quantity of chemicals the facility will deal with," says Bob Mulvey, assistant municipal utilities director for the city of Chandler. "There won't be any negative environmental impacts from the company."

Last week, the city of Chandler filed a motion to dismiss the lawsuit. And Mr. Kinburn says he will file a motion for partial summary judgment.

Meanwhile, Covance is proceeding with construction of a 300,000-square-foot laboratory in Chandler, with an expected opening in mid-2009. "We anticipate employing in the neighborhood of 300 to 400 people," says Camilla Strongin, spokeswoman for Covance. "If the business climate is as favorable as we hope, the additional acreage will be beneficial for future expansion."

Permissions